Shanghai Serum Bio-Technology Co., Ltd. (SHA:688163)

SHA:688163 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	133.34	182.11	150.92	515.73	115.88	-
Short-Term Investments	17.79	9.26	-	-	-	118.24
Trading Asset Securities	611.87	641.21	722.59	417.62	65.15	-
Cash & Short-Term Investments	763	832.58	873.51	933.35	181.03	118.24
Cash Growth	-8.32%	-4.69%	-6.41%	415.59%	53.10%	-19.52%
Accounts Receivable	98.58	36.68	22.63	7.68	9.59	3.62
Other Receivables	1.07	0.86	0.8	0.98	6.25	4.06
Receivables	99.65	37.54	23.43	8.66	15.84	7.68
Inventory	42.41	43.28	44.75	54.53	49.18	49.72
Other Current Assets	2.85	2.97	7.24	0.51	1.89	4.12
Total Current Assets	907.9	916.36	948.93	997.05	247.93	179.76
Property, Plant & Equipment	174.61	157.34	127.82	117.42	103.67	68.55
Long-Term Investments	-	-	16.59	17.35	19.81	22.51
Other Intangible Assets	22.86	23.03	23.79	24.24	23.97	25.15
Long-Term Deferred Tax Assets	8.54	8	9.91	9.29	5.09	5.31
Long-Term Deferred Charges	0.51	0.63	0.87	1.11	1.35	1.59
Other Long-Term Assets	21.09	14.66	0.55	0.02	1.06	9.26
Total Assets	1,136	1,120	1,128	1,166	402.89	312.15
Accounts Payable	1.89	1.31	3.64	4.28	2.47	2.12
Accrued Expenses	11.45	14.57	16.92	17.05	11.48	9.14
Current Portion of Leases	0.31	0.29	0.76	1.37	1.33	-
Current Income Taxes Payable	4.57	-	-	1.51	0.4	-
Current Unearned Revenue	3.73	2.2	2.93	1.99	1.44	3.25
Other Current Liabilities	2.03	1.24	0.75	0.68	0.53	0.44
Total Current Liabilities	23.98	19.62	24.99	26.87	17.65	14.95
Long-Term Leases	3.84	4	12.2	12.31	13.02	-
Long-Term Deferred Tax Liabilities	0.87	0.91	5.45	5.67	2.59	2.59
Total Liabilities	28.69	24.53	42.63	44.86	33.26	17.54
Common Stock	108.22	108.22	108.22	108.22	81.16	81.16
Additional Paid-In Capital	878.09	878.09	878.09	871.49	113.62	113.62
Retained Earnings	120.53	109.19	99.53	141.92	174.84	99.82
Total Common Equity	1,107	1,096	1,086	1,122	369.63	294.61
Shareholders' Equity	1,107	1,096	1,086	1,122	369.63	294.61
Total Liabilities & Equity	1,136	1,120	1,128	1,166	402.89	312.15
Total Debt	4.15	4.3	12.96	13.68	14.35	-
Net Cash (Debt)	758.85	828.28	860.55	919.66	166.68	118.24
Net Cash Growth	-7.41%	-3.75%	-6.43%	451.75%	40.97%	-19.52%
Net Cash Per Share	6.95	7.67	7.99	9.02	2.05	1.46
Filing Date Shares Outstanding	108.22	108.22	108.22	108.22	81.16	81.16
Total Common Shares Outstanding	108.22	108.22	108.22	108.22	81.16	81.16
Working Capital	883.92	896.74	923.94	970.18	230.29	164.82
Book Value Per Share	10.23	10.12	10.03	10.36	4.55	3.63
Tangible Book Value	1,084	1,072	1,062	1,097	345.66	269.46
Tangible Book Value Per Share	10.02	9.91	9.81	10.14	4.26	3.32
Buildings	121.51	121.51	64.9	60.97	58.87	58.87
Machinery	70.27	71.64	67.04	62.65	55.95	49.69
Construction In Progress	63.65	41.84	54.6	43.14	29.52	5.75

Source: S&P Global Market Intelligence. Standard template. Financial Sources.